Women with BRCA1 or BRCA2 gene mutations should undergo annualbreast cancer screening with magnetic resonance imaging from theage of 25 onward, as should women who have first-degreerelatives with a proven mutation (category Arecommendation). The gene discussed is BRCA1; the disease is cancer.